Processa Pharmaceuticals (PCSA) Return on Invested Capital (2014 - 2021)

Processa Pharmaceuticals (PCSA) has 7 years of Return on Invested Capital data on file, last reported at 1.31% in Q4 2021.

• Quarterly Return on Invested Capital fell 125.0% year-over-year to 1.31% in Q4 2021, while the trailing twelve-month figure through Dec 2021 was 1.31% (down 125.0% YoY) and the FY2021 annual result came in at 3.24%, down 291.0% from the prior year.
• Return on Invested Capital declined to 1.31% in Q4 2021, from 0.36% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q3 2017 to a low of 24.16% in Q3 2018.
• A 5-year average of 1.5% and a median of 0.07% in 2019 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2018 — Return on Invested Capital slumped 2415 bps — and 2019, when it surged 2409 bps.
• Tracing PCSA's Return on Invested Capital over 5 years: stood at 0.02% in 2017, then sank by 1706 bps to 0.31% in 2018, then soared by 86 bps to 0.04% in 2019, then tumbled by 31 bps to 0.06% in 2020, then slumped by 2208 bps to 1.31% in 2021.
• The last three Return on Invested Capital figures came in at 1.31% (Q4 2021), 0.36% (Q3 2021), and 0.16% (Q2 2021), per Business Quant data.